Switching Aerosol Manufacturers: How to Transfer Production Safely
Changing aerosol manufacturer can improve supply resilience, capacity, technical support, commercial flexibility or access to specialist filling technologies. But transferring an established aerosol is not as simple as sending a formula to a new factory and asking it to reproduce the existing product.
Aerosols are integrated systems. The formulation, raw materials, manufacturing method, propellant, can, internal lining, valve, actuator, filling parameters and quality controls all contribute to the performance of the finished product. A seemingly small change during transfer can therefore affect spray pattern, pressure, compatibility, stability, product evacuation or shelf life.
Hydrokem supports brands transferring existing aerosol and Bag-on-Valve products into UK contract manufacture. A controlled transfer protects product consistency while giving commercial, technical and procurement teams a clear route from initial review through trial production and validation to routine supply.
Why Do Brands Change Aerosol Manufacturers?
A decision to change manufacturer is usually driven by commercial or operational need rather than by the product itself. The aerosol may already be established in the market and performing successfully, but the existing manufacturing arrangement no longer supports the brand’s objectives.
Capacity constraints
Growing volumes can expose limitations in available line time, batch sizes or the ability of the existing supplier to support future demand.
Supply reliability
Long lead times, component shortages, missed production dates or poor communication can make continuity of supply increasingly difficult to manage.
Technical capability
A brand may require Bag-on-Valve, specialist components, regulated-sector experience or more advanced testing than its current supplier can provide.
Commercial requirements
MOQ, production costs, component sourcing or changing forecast volumes may make the existing manufacturing model less competitive.
Supplier consolidation
Brands may want to move several SKUs to one specialist partner to simplify procurement, quality management and supply-chain coordination.
Strategic reshoring
Businesses manufacturing overseas may seek UK production to shorten supply chains, increase visibility or reduce exposure to international disruption.
Can You Move an Existing Aerosol to Another Manufacturer?
Yes. Existing aerosol products can normally be transferred to another suitable contract manufacturer, provided the necessary formulation, component, process and quality information is available and the new manufacturing process is properly assessed.
The objective is usually to reproduce the established product as closely as necessary while identifying where changes are unavoidable or commercially beneficial.
Some projects can transfer with the same formula and components. Others may require alternative valves, actuators, propellants, raw-material suppliers or packaging because the original specification is unavailable, proprietary to the former manufacturer or incompatible with the new production equipment.
That distinction matters. A direct transfer is primarily a process-equivalence exercise. A transfer involving component or formulation changes becomes partly a redevelopment project and may require additional testing.
Brands should therefore avoid describing a transfer as simply “moving the filling”. The complete aerosol system needs to be understood before the new manufacturing specification is approved.
What Information Does the New Manufacturer Need?
The quality of the transfer depends heavily on the technical package available at the outset. More complete information allows the new manufacturer to identify equivalence risks earlier and reduces avoidable trial-and-error work.
| Information | Why it matters |
|---|---|
| Formula and manufacturing method | Defines ingredients, concentrations, mixing order, temperatures and processing requirements. |
| Raw-material specifications | Helps determine whether identical or technically equivalent materials can be sourced. |
| Can specification | Confirms dimensions, material, pressure rating, lining and decoration. |
| Valve and actuator details | Critical for flow rate, spray pattern, sealing and dispensing performance. |
| Propellant specification | Can influence pressure, atomisation, formulation behaviour and transport classification. |
| Finished-product specification | Establishes measurable acceptance criteria for transferred production. |
| Stability and compatibility data | Provides evidence about the behaviour of the existing formula and packaging system. |
| Quality and test methods | Enables the new manufacturer to understand how existing product quality is assessed. |
| Annual volumes and forecasts | Allows production capacity, component ordering and commercial fit to be assessed. |
Where documentation is incomplete, Hydrokem can identify what must be reconstructed or established through samples, specifications and development work before transfer proceeds.
Who Owns the Aerosol Formula?
Formula ownership should be established before a manufacturing transfer begins.
Some brands own their complete formulation and technical specification. In other arrangements, the existing manufacturer may own the formulation or certain elements of the manufacturing know-how. Private-label products can create additional complexity where the brand owns the name and packaging but not necessarily the underlying formula.
The transferring business should establish:
- Who owns the formulation?
- Does the brand have the right to transfer it?
- Who owns the manufacturing process?
- Are ingredient percentages available?
- Can existing technical documents legally be shared?
- Are particular raw-material suppliers mandatory?
- Does any confidentiality agreement restrict disclosure?
- Are packaging specifications owned by the brand or supplier?
If the original formula cannot be transferred, a new manufacturer may be able to develop an alternative formulation targeting the required product characteristics. However, this should be treated as development rather than simple technology transfer.
Do the Same Aerosol Components Need to Be Used?
Where practical, retaining the existing can, valve, actuator and propellant can reduce variables during a manufacturing transfer. However, using exactly the same components is not always possible or commercially desirable.
A component may be proprietary to the previous supplier, discontinued, available only at unsuitable minimum quantities or incompatible with the new manufacturer’s equipment.
If an alternative is proposed, apparent similarity is not enough. Small differences in valve orifices, gasket materials, actuator geometry, dip-tube dimensions or can linings can influence the finished aerosol.
- Compare old and proposed component specifications.
- Identify differences in product-contact materials.
- Review valve flow characteristics and sealing materials.
- Compare actuator spray behaviour.
- Confirm can material, dimensions and internal lining.
- Assess propellant and pressure implications.
- Produce representative trial packs.
- Complete proportionate compatibility and performance testing.
Hydrokem’s guide to choosing the right aerosol components explains how cans, valves, actuators, dip tubes and propellants influence the complete product system.
Will Compatibility and Stability Testing Need to Be Repeated?
Possibly. The answer depends on how closely the new manufacturing system matches the established product and whether any product-contact materials or manufacturing conditions change.
Existing stability data remains valuable, particularly where the formula and complete packaging system remain unchanged. However, transferring manufacture can introduce new variables such as raw-material sources, blending conditions, valve components, can linings or filling parameters.
A technical risk assessment should determine what evidence can reasonably be relied upon and what needs to be confirmed again.
Testing may consider:
- formula appearance and stability;
- pack integrity and leakage;
- internal and external corrosion;
- valve and gasket compatibility;
- pressure behaviour;
- spray pattern and discharge rate;
- product evacuation;
- actuator performance;
- finished-product specification compliance.
See Hydrokem’s guide to aerosol compatibility testing for more detail on how the formula and pack are assessed together.
How a Safe Aerosol Manufacturing Transfer Works
Confidential project review
Define the reasons for transfer, product range, existing manufacturer, required timing, annual volumes and commercial objectives.
Technical information transfer
Review formulas, ingredients, components, packaging specifications, quality criteria and existing validation evidence.
Gap and risk assessment
Identify where the proposed Hydrokem process differs from the existing production method and which differences require investigation.
Component and supply review
Confirm which existing components can remain and where equivalent or alternative suppliers may be needed.
Trial manufacture
Produce representative packs using the intended formula, components, propellant and production conditions.
Testing and approval
Compare trial production with the approved finished-product specification and complete proportionate compatibility or stability work.
Commercial production planning
Order components, agree batch quantities, schedule production and establish finished-goods and supply requirements.
Controlled production transfer
Manufacture the first commercial batches with agreed controls, inspection, coding, documentation and release criteria.
Ongoing supply
Review performance, forecasts, component availability and future manufacturing schedules once routine supply is established.
How Do You Avoid Interrupting Existing Supply?
Supply continuity should be considered from the beginning of a manufacturer-transfer project. Waiting until the new product is validated before thinking about stock can leave a gap between the final batch from the former supplier and the first commercial batch from the new manufacturer.
A transition plan should work backwards from forecast demand and available inventory.
- Calculate current finished-goods stock cover.
- Confirm the last production opportunity with the existing manufacturer.
- Allow realistic time for technical transfer and trials.
- Identify long-lead components early.
- Build appropriate safety stock where practical.
- Consider overlapping supply during validation.
- Plan market or SKU transfer in stages where appropriate.
- Do not terminate the existing supply route prematurely.
For larger portfolios, moving selected SKUs first can reduce commercial risk. Once the initial products are running successfully, the remaining range can follow using the established transfer process.
Should You Run the Old and New Manufacturers in Parallel?
Parallel production can be a useful risk-management strategy where continuity of supply is critical.
The existing manufacturer continues to provide product while Hydrokem completes transfer activity and produces initial batches. This provides a buffer if development, testing, components or production scheduling take longer than expected.
Parallel supply is not necessary for every project. Maintaining two production routes can increase inventory and management complexity. However, it may be appropriate for high-volume products, regulated sectors, products with long replenishment cycles or brands with limited tolerance for out-of-stock situations.
The decision should be based on:
- current stock cover;
- forecast demand;
- product criticality;
- technical transfer complexity;
- testing timescales;
- component lead times;
- commercial risk of supply interruption.
How Much Does Switching Aerosol Manufacturer Cost?
A manufacturing transfer can involve costs beyond routine filling because the new supplier must establish that the product can be manufactured consistently within its own processes and quality systems.
The commercial impact depends on how closely the new process matches the existing specification.
Simple transfer
An established customer-owned formula using readily available components and good technical documentation may require relatively limited redevelopment.
Component change
Alternative valves, actuators, cans or propellants can require trial work and additional compatibility assessment.
Incomplete technical package
Missing formula, specifications or testing records may require additional investigation before a robust production specification can be created.
Reformulation
If the original formula cannot be transferred, developing an equivalent or improved formulation becomes a separate technical project.
Other cost factors can include component minimum orders, bespoke printed cans, testing, line trials, artwork changes and initial commercial batch size.
If cost is an important part of your supplier review, read our detailed guide to how much aerosol contract manufacturing costs in the UK. It explains how formulation, packaging, MOQ, testing and production volume affect the commercial model.
What Should You Compare When Evaluating a New Manufacturer?
A transfer decision should not be based on unit cost alone. The new supplier becomes part of the product’s technical and commercial infrastructure.
| Area | Questions to ask |
|---|---|
| Technical capability | Can the manufacturer reproduce the formulation, pack and required dispensing performance? |
| Quality | How are specifications, batch records, traceability and release controls managed? |
| Components | Can existing components be retained, and what alternatives are available? |
| Testing | What validation is recommended before routine production? |
| Capacity | Can the supplier support current volumes and future growth? |
| MOQ | Do production and component minimums fit the commercial model? |
| Lead times | How far in advance must components and production be scheduled? |
| Communication | Who owns the transfer project and how are risks and decisions communicated? |
| Cost | Does the quotation include the complete manufacturing and packaging requirement? |
For a broader procurement checklist, see How to Choose the Right Aerosol Manufacturer in the UK.
Moving Production to Hydrokem
Hydrokem supports both new product development and the controlled transfer of established aerosol and Bag-on-Valve products.
Our involvement can include technical review, formula transfer, concentrate blending, component sourcing, aerosol and BoV filling, trial manufacture, compatibility assessment, production specifications, secondary packaging and commercial supply.
Because Hydrokem is focused on contract manufacturing rather than competing consumer brands, our technical and production resources are dedicated to manufacturing products for our customers.
- Confidential review of existing products and specifications.
- Formula and manufacturing-process assessment.
- Aerosol and Bag-on-Valve production capability.
- Can, valve, actuator and propellant sourcing.
- Compatibility and finished-pack testing support.
- Controlled trial and commercial production.
- Batch coding and traceability.
- Supply-chain and repeat-production planning.
For direct details of our capabilities, visit Hydrokem’s UK aerosol contract manufacturing service.
Frequently Asked Questions
Yes. An established aerosol product can usually be transferred to another UK contract manufacturer, provided the new supplier has the appropriate technical and production capability. The transfer should be managed as a controlled technical project rather than treating it simply as moving the filling operation from one factory to another. Aerosol performance depends on the formulation, raw materials, can, internal lining, valve, actuator, propellant and manufacturing process working together.
The new manufacturer will normally review the formula, manufacturing instructions, raw-material specifications, packaging components, finished-product specification and any existing stability or compatibility data. It will then compare the current process with the proposed manufacturing route and identify any differences that could affect performance.
Where the same formula and components can be retained, the transfer may be relatively straightforward. If a component is unavailable or the original manufacturer owns part of the formulation, additional development may be necessary. Representative production trials are often used to confirm that the transferred product meets the established specification before routine commercial manufacture begins.
Supply planning should run alongside the technical transfer. Existing stock, the former supplier’s final production date, testing timescales and component lead times should all be considered so that changing manufacturer does not create an avoidable gap in product availability.
Some testing may be required when an aerosol moves to a new manufacturer, but the extent depends on what changes during the transfer. If the formulation, raw materials, can, valve, actuator, propellant and finished-product specification remain genuinely equivalent, existing stability and compatibility evidence may remain highly relevant. The new manufacturer should still establish that its production process can reproduce the approved product consistently.
Additional testing becomes more important when product-contact materials or manufacturing conditions change. For example, an alternative valve may use a different gasket material, a replacement can may have another internal lining, or a new actuator may alter spray characteristics. A change in raw-material supplier or propellant can also affect the finished system.
A risk-based transfer assessment can determine which existing evidence can be relied upon and which aspects should be verified again. Trial packs may be assessed for pressure, leakage, corrosion, spray pattern, discharge rate, product evacuation, formula appearance and other product-specific quality criteria. Longer-term compatibility or stability work may be appropriate where the transfer introduces significant changes.
The objective is not to repeat every previous test automatically. It is to generate sufficient evidence that the transferred product remains safe, stable and commercially equivalent to the approved specification before routine production is established at the new manufacturing site.
Changing aerosol manufacturer without interrupting supply requires the technical transfer and inventory plan to be managed together. One of the biggest mistakes is ending the existing manufacturing relationship before the replacement product has completed trials, validation, component procurement and production planning. A brand should first calculate how much finished stock it holds and how long that stock will cover expected demand.
The next step is to establish the likely transfer timetable. This should include technical-document review, component sourcing, trial production, testing, artwork changes where required, procurement lead times and the first commercial manufacturing slot. Long-lead items such as printed cans or specialist valves need particular attention.
Where continuity is critical, the brand may place a final production order with its current supplier while the new manufacturer completes the transfer. Larger or more complex portfolios can also be moved in phases, beginning with selected SKUs before transferring the remainder once the process has been proven.
Some businesses choose a period of parallel supply in which the existing manufacturer remains available while initial batches from the new supplier enter the market. Although this requires careful inventory management, it can reduce the commercial risk of a sudden cutover. The correct approach depends on stock cover, product criticality, technical complexity, component lead times and the cost of an out-of-stock situation.
If your current manufacturer owns the formulation, the first step is to review the commercial and intellectual-property arrangements governing the product. A brand may own the product name, artwork and customer relationships without owning the detailed formula or manufacturing method. This is particularly possible with private-label or manufacturer-developed products where the supplier created the formulation as part of its own technical platform.
The contract or development agreement should establish whether the formulation can be transferred, licensed or purchased and whether technical information may be disclosed to another manufacturer. Brands should not assume that paying for finished goods automatically gives them ownership of the underlying formula.
If the existing formulation cannot legally or practically be transferred, the new manufacturer may be able to develop a replacement product intended to meet the required performance characteristics. In that situation, the project becomes a new development or reformulation rather than an exact production transfer. The brand should define the characteristics that matter most, such as spray pattern, application performance, fragrance, drying behaviour, foam, viscosity or other measurable properties.
The new formulation and packaging system will then require appropriate technical assessment and testing before commercial launch. Establishing formula ownership early prevents wasted transfer work and gives the brand a realistic choice between negotiating access to the existing specification and commissioning a new manufacturing-ready formulation.
The cost of transferring an aerosol to a new manufacturer depends on how much technical and commercial work is required before routine production can begin. A well-documented product using a customer-owned formulation and readily available components may involve relatively limited transfer work. The new manufacturer still needs to review the specification and establish that the product can be reproduced on its equipment, but fewer variables may need redevelopment.
Costs can increase when cans, valves, actuators, propellants or raw materials need to change. Alternative product-contact components may require new trial batches, compatibility work or additional stability evidence. If the brand does not own the existing formulation, creating a replacement formula becomes a separate development project. Bespoke printed packaging can also introduce minimum order quantities and tooling or artwork commitments.
Production volume affects the commercial model as well. Setup and development costs are spread across fewer units on smaller initial runs, while larger repeat programmes can provide greater production and procurement efficiency. Brands should also consider the cost of safety stock or parallel supply during the transfer rather than evaluating only the first manufacturing quotation.
For a detailed explanation of formulation, packaging, testing, MOQ and production cost drivers, read Hydrokem’s guide to how much aerosol contract manufacturing costs in the UK.
Considering Changing Your Aerosol Manufacturer?
Talk to Hydrokem confidentially about transferring an existing aerosol or Bag-on-Valve product, reviewing your formulation and components, validating production and planning continuity of supply.
Discuss a Production Transfer
